Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8

Agree muya - result ok and improved from previous quarter but nothing to say well done about. Previous 12 months dec quarter was 1.4mill v
this 810k so the bet on China still hasn’t worked as sales over the last 12 months have not eventuated as what was hoped. The last over 2 million quarter was back in April 2020.
In saying the share price has deteriorated significantly because of the lack of sales growth or major partnerships or distribution deals and is now almost halving over the same 12 month time frame as shareholders give up on the story and now sits at a single digit price as people give up waiting.
Cap raise price didn’t even hold for a month and Market cap less the $5 mill cash is at an embarrassing level and in my opinion significantly discounted but is unlikely to create any enthusiasm for new buyers so unless a significant deal can be done is probably not going to improve.
Good luck to those patient enough to believe and waiting on the Amazon , csl and buffet type stories that are pushed but I am moving on knowing it’s cheap but not worth the wait on the ever told China story that hopefully one day finally eventuates for these incredible Australian medical devices.
enjoy the journey